Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

次世代シーケンシング(NGS)サービスの世界市場予測(~2022年)

◆タイトル:Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022
◆商品コード:MAM-BT5526
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年8月24日
◆ページ数:159
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、次世代シーケンシング(NGS)サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、技術別分析、用途別分析、地域別分析、次世代シーケンシング(NGS)サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%”The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing, the high cost of sequencing infrastructure, the need for skilled professionals for efficient NGS sample preparation and analysis, and technological advancements in the field of sequencing are driving the growth of this market. However, installation of in-house sequencing facilities in hospitals and universities is expected to limit the optimal market growth for NGS services during the forecast period

“Targeted resequencing & custom gene panels are expected to grow at the highest CAGR during 2017 to 2022”
By type, the global NGS services market covers targeted resequencing & custom gene panels, RNA-Seq, de novo sequencing, exome sequencing, CHiP-Seq, whole-genome sequencing, methyl-seq, and other services. The targeted resequencing & custom gene panels segment is expected to grow at the highest CAGR during 2017 to 2022. Targeted sequencing/gene panels allow researchers to focus on the subset of genes or region, which reduces the time consumed for sequencing, the cost of sequencing, and simplifies data analysis.

“Sequencing by synthesis technology to dominate the global NGS services market during the forecast period”
By technology, the NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. The SBS segment is estimated to account for the largest share of the NGS services market in 2017. The introduction of technologically advanced SBS platforms and decreasing cost of sequencing are the major factors driving the growth of the SBS segment.

“APAC is projected to witness the highest growth during the forecast period “
While North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. This is owing to increasing incidence of target diseases, rising awareness regarding the benefits of NGS-based clinical applications, and growing research activity in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type – Tier 1 –31%, Tier 2 –48% and Tier 3 –21%
• By Designation – C level – 26%, Director level – 24%, Others – 50%
• By Region – North America – 29%, Europe – 35%, APAC – 21%, RoW – 15%

As of 2016, major players operating in the global NGS services market are BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), and GATC Biotech AG (Germany) among others.

Research Coverage
This report studies the NGS services market-based on type, technology, application, and end user. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four main regions.

Reasons to Buy the Report:
This research focuses on various levels of analysis—competitive leadership analysis of 25 market players, and company profiles of top 15 market players—which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS services market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on business strategies adopted by the major players in the NGS services market. The report analyzes the NGS services market-based on types, technology, application, end user, and region.

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product & service launches in the NGS services.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS services across geographies.

• Market Diversification: Exhaustive information about new NGS services, untapped geographies, recent developments, and investments in the NGS services market.

• Competitive Assessment: In-depth assessment of market ranking, strategies, products and services, and sequencing capabilities of leading players in the NGS services market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 15
1.2.2 YEARS CONSIDERED FOR THE STUDY 15
1.3 CURRENCY 16
1.4 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH APPROACH 17
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.2.1 SECONDARY RESEARCH 19
2.2.1.1 Key data from secondary sources 19
2.2.2 PRIMARY DATA 20
2.2.2.1 Breakdown of primaries 20
2.2.2.2 Key data from primary sources 21
2.2.2.3 Key industry insights 22
2.3 MARKET SIZE ESTIMATION 23
2.3.1 BOTTOM-UP APPROACH 23
2.3.2 TOP-DOWN APPROACH 24
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 31
4.1 NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET OVERVIEW 31
4.2 GLOBAL NGS SERVICES MARKET, BY TYPE, 2015 VS. 2017 VS. 2022 (USD MILLION) 32
4.3 GEOGRAPHIC ANALYSIS: NGS SERVICES MARKET, BY TECHNOLOGY (2017) 32
4.4 NGS SERVICES MARKET, BY APPLICATION 33
4.5 GLOBAL NGS SERVICES MARKET, BY END USER, 2017 VS. 2022 33
4.6 GEOGRAPHICAL SNAPSHOT OF THE NGS SERVICES MARKET 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Declining price of sequencing 37
5.2.1.2 High cost of sequencing infrastructure 38
5.2.1.3 Need for skilled professionals for efficient NGS sample preparation and analysis 38
5.2.1.4 Sequencing services, the preferred option for NGS applications with low throughput requirements 38
5.2.1.5 Technological advancements in the field of sequencing 39
5.2.2 RESTRAINTS 39
5.2.2.1 Installation of in-house sequencing facilities in hospitals and universities 39
5.2.3 OPPORTUNITIES 39
5.2.3.1 Analysis of complex sequencing data 39
5.2.3.2 Increasing applications in cancer and agrigenomics research 40
5.2.4 CHALLENGES 40
5.2.4.1 Accuracy & standardization concerns in diagnostic testing 40
5.2.4.2 Ethical issues related to NIPT 41

6 GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY TECHNOLOGY 42
6.2 INTRODUCTION 43
6.3 SEQUENCING BY SYNTHESIS 44
6.4 ION SEMICONDUCTOR SEQUENCING 45
6.5 SINGLE-MOLECULE REAL-TIME SEQUENCING 46
6.6 NANOPORE SEQUENCING 47

7 GLOBAL NGS SERVICES MARKET, BY SERVICE TYPE 49
7.1 INTRODUCTION 50
7.2 TARGETED RESEQUENCING & CUSTOM GENE PANELS 51
7.3 RNA-SEQ 52
7.4 DE NOVO SEQUENCING 53
7.5 EXOME SEQUENCING 54
7.6 CHIP-SEQ 55
7.7 WHOLE-GENOME SEQUENCING 56
7.8 METHYL-SEQ 57
7.9 OTHER SERVICES 58

8 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION 59
8.1 INTRODUCTION 60
8.2 DIAGNOSTICS 61
8.2.1 ONCOLOGY 63
8.2.2 INFECTIOUS DISEASES 64
8.2.3 RARE GENETIC DISORDERS 64
8.2.4 REPRODUCTIVE HEALTH 65
8.2.5 OTHER DIAGNOSTIC APPLICATIONS 65
8.3 DRUG DISCOVERY 66
8.4 BIOMARKER DISCOVERY 67
8.5 AGRICULTURE & ANIMAL RESEARCH 69
8.6 OTHER APPLICATIONS 70

9 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER 72
9.1 INTRODUCTION 73
9.1.1 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS 74
9.1.2 HOSPITALS & CLINICS 75
9.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 76
9.1.4 OTHER END USERS 77

10 GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION 78
10.1 INTRODUCTION 79
10.2 NORTH AMERICA 80
10.2.1 U.S. 84
10.2.2 CANADA 85
10.3 EUROPE 86
10.3.1 GERMANY 90
10.3.2 U.K. 91
10.3.3 FRANCE 91
10.3.4 REST OF EUROPE 92
10.4 ASIA-PACIFIC 93
10.4.1 CHINA 97
10.4.2 JAPAN 98
10.4.3 INDIA 99
10.4.4 REST OF ASIA-PACIFIC 100
10.5 REST OF THE WORLD 101

11 COMPETITIVE LANDSCAPE 105
11.1 INTRODUCTION 105
11.2 MARKET RANKING ANALYSIS 105
11.3 COMPETITIVE LEADERSHIP BENCHMARKING 106
11.3.1 VISIONARY LEADERS 106
11.3.2 INNOVATORS 106
11.3.3 DYNAMIC DIFFERENTIATORS 106
11.3.4 EMERGING COMPANIES 106
11.4 STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS) 108
11.5 BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS) 109
*Top 25 companies analyzed for this study are – Illumina, Inc., BGI, Eurofins Scientific SE, PerkinElmer, Inc., QIAGEN N.V., GATC Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Inc., Takara Bio Inc., SciGenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics BioSci & Tech. Co., Ltd., Zymo Research Corp, Source BioScience, IntegraGen SA, CENTOGENE AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.

12 COMPANY PROFILES 110
12.1 INTRODUCTION 110
(OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
12.2 BGI 110
12.3 ILLUMINA, INC. 113
12.4 PERKINELMER, INC. 116
12.5 EUROFINS SCIENTIFIC SE 119
12.6 GATC BIOTECH AG 122
12.7 MACROGEN, INC. 125
12.8 QIAGEN N.V. 127
12.9 GENOTYPIC TECHNOLOGY PVT. LTD. 130
12.10 GENEWIZ, INC. 132
12.11 DNA LINK, INC. 134
12.12 TAKARA BIO INC. (PART OF TAKARA HOLDING COMPANY INC.) 136
12.13 SCIGENOM LABS PVT. LTD 139
12.14 NOVOGENE CORPORATION 141
12.15 PERSONALIS, INC. 143
12.16 LGC LIMITED (A PART OF KKR & CO. L.P.) 145
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

13 APPENDIX 147
13.1 DISCUSSION GUIDE 147
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 154
13.4 AVAILABLE CUSTOMIZATIONS 155
13.5 RELATED REPORTS 156
13.6 AUTHOR DETAILS 157

LIST OF TABLES

TABLE 1 NGS SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 2 NGS SERVICES MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 3 NGS SERVICES MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2015–2022 (USD MILLION) 46
TABLE 4 NGS SERVICES MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING,
BY REGION, 2015–2022 (USD MILLION) 47
TABLE 5 NGS SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION,
2015–2022 (USD MILLION) 48
TABLE 6 NGS SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 50
TABLE 7 TARGETED SEQUENCING SERVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 8 RNA-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 9 DE NOVO SEQUENCING SERVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 10 EXOME SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 55
TABLE 11 CHIP-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 56
TABLE 12 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 57
TABLE 13 METHYL-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 14 OTHER NGS SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 60
TABLE 16 NGS DIAGNOSTIC SERVICES MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 62
TABLE 17 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 63
TABLE 18 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DRUG DISCOVERY,
BY REGION, 2015–2022 (USD MILLION) 67
TABLE 19 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 20 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 21 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 22 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER,
2015–2022 (USD MILLION) 73
TABLE 23 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS, BY REGION,
2015–2022 (USD MILLION) 75
TABLE 24 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2022 (USD MILLION) 76
TABLE 25 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 77
TABLE 26 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER END USERS,
BY REGION, 2015–2022 (USD MILLION) 77
TABLE 27 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 80
TABLE 28 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 81
TABLE 29 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 82
TABLE 30 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY TECHNOLOGY, 2015–2022 (USD MILLION) 82
TABLE 31 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 83
TABLE 32 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY END USER, 2015–2022 (USD MILLION) 83
TABLE 33 U.S.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 84
TABLE 34 CANADA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 85
TABLE 35 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 88
TABLE 36 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 88
TABLE 37 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 89
TABLE 38 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 89
TABLE 39 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 90
TABLE 40 GERMANY: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY TECHNOLOGY, 2015–2022 (USD MILLION) 90
TABLE 41 U.K.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 91
TABLE 42 FRANCE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 92
TABLE 43 ROE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 92
TABLE 44 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 95
TABLE 45 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 95
TABLE 46 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY TECHNOLOGY, 2015–2022 (USD MILLION) 96
TABLE 47 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 96
TABLE 48 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 97
TABLE 49 CHINA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 98
TABLE 50 JAPAN: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 98
TABLE 51 INDIA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 99
TABLE 52 ROAPAC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 100
TABLE 53 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 103
TABLE 54 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 103
TABLE 55 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 104
TABLE 56 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER,
2015–2022 (USD MILLION) 104


LIST OF FIGURES

FIGURE 1 GLOBAL NGS SERVICES MARKET: RESEARCH APPROACH 17
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 20
FIGURE 4 NGS SERVICES MARKET: BOTTOM-UP APPROACH 23
FIGURE 5 NGS SERVICES MARKET: TOP-DOWN APPROACH 24
FIGURE 6 NGS SERVICES MARKET: DATA TRIANGULATION 25
FIGURE 7 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2017 VS. 2022 27
FIGURE 8 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY,
2017 VS. 2022 (USD MILLION) 28
FIGURE 9 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION,
2017 VS. 2022 (USD MILLION) 28
FIGURE 10 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER,
2017 VS. 2022 (USD MILLION) 29
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE NEXT-GENERATION SEQUENCING SERVICES MARKET 30
FIGURE 12 INCREASING APPLICATIONS OF NGS IN CANCER AND AGRIGENOMICS RESEARCH TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 31
FIGURE 13 NORTH AMERICA TO DOMINATE THE NGS SERVICES MARKET IN 2017 32
FIGURE 14 AGRICULTURE & ANIMAL RESEARCH SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE NGS SERVICES MARKET BETWEEN 2017 & 2022 33
FIGURE 15 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NGS SERVICES MARKET IN 2022 33
FIGURE 16 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 34
FIGURE 17 NEXT-GENERATION SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 18 HUMAN WHOLE-GENOME SEQUENCING COST ESTIMATED BY THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE 37
FIGURE 19 NANOPORE SEQUENCING TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2017 TO 2022) 43
FIGURE 20 NGS SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 43
FIGURE 21 TARGETED RESEQUENCING/CUSTOM GENE PANELS SEGMENT WILL
CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING
SERVICES MARKET IN 2022 50
FIGURE 22 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET IN 2022 61
FIGURE 23 GROWTH IN NUMBER OF GENETIC TESTS (2012–2016) 62
FIGURE 24 INCREASING PUBLICATIONS RELATED TO BIOMARKER DISCOVERY BASED ON NGS DURING 2011-2016 67
FIGURE 25 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 73
FIGURE 26 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION 79
FIGURE 27 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 81
FIGURE 28 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 87
FIGURE 29 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 94
FIGURE 30 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 102
FIGURE 31 BGI, EUROFINS SCIENTIFIC SE, AND MACROGEN WERE THE LEADING PROVIDERS FOR NGS SERVICES WORLDWIDE IN 2016 105
FIGURE 32 NGS SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017 107
FIGURE 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2016) 113
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2016) 116
FIGURE 35 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2016) 119
FIGURE 36 MACROGEN, INC.: COMPANY SNAPSHOT (2015) 125
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2016) 127
FIGURE 38 TAKARA BIO INC.: COMPANY SNAPSHOT (2016) 136


【レポートのキーワード】

次世代シーケンシング、NGSサービス、イオン半導体、SMRT、ナノポア、次世代シーケンシング技術

★調査レポート[次世代シーケンシング(NGS)サービスの世界市場予測(~2022年)] ( Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022 / MAM-BT5526) 販売に関する免責事項
[次世代シーケンシング(NGS)サービスの世界市場予測(~2022年)] ( Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022 / MAM-BT5526) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆